165 related articles for article (PubMed ID: 22221159)
1. Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.
Birbeck GL; French JA; Perucca E; Simpson DM; Fraimow H; George JM; Okulicz JF; Clifford DB; Hachad H; Levy RH; ;
Epilepsia; 2012 Jan; 53(1):207-14. PubMed ID: 22221159
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.
Birbeck GL; French JA; Perucca E; Simpson DM; Fraimow H; George JM; Okulicz JF; Clifford DB; Hachad H; Levy RH; ;
Neurology; 2012 Jan; 78(2):139-45. PubMed ID: 22218281
[TBL] [Abstract][Full Text] [Related]
3. The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control study.
Okulicz JF; Grandits GA; French JA; Perucca E; George JM; Landrum ML; Acosta EP; Birbeck GL
Epilepsy Res; 2013 Feb; 103(2-3):245-53. PubMed ID: 22835761
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant and antiretroviral interactions.
Liedtke MD; Lockhart SM; Rathbun RC
Ann Pharmacother; 2004 Mar; 38(3):482-9. PubMed ID: 14970370
[TBL] [Abstract][Full Text] [Related]
5. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
[No Abstract] [Full Text] [Related]
6. Warfarin-antiretroviral interactions.
Liedtke MD; Rathbun RC
Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions between chemotherapeutic regimens and antiepileptics.
Yap KY; Chui WK; Chan A
Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
[TBL] [Abstract][Full Text] [Related]
8. The Spanish Society of Neurology's official clinical practice guidelines for epilepsy. Special considerations in epilepsy: comorbidities, women of childbearing age, and elderly patients.
Mauri Llerda JA; Suller Marti A; de la Peña Mayor P; Martínez Ferri M; Poza Aldea JJ; Gomez Alonso J; Mercadé Cerdá JM
Neurologia; 2015 Oct; 30(8):510-7. PubMed ID: 25618222
[TBL] [Abstract][Full Text] [Related]
9. Appendix D. Summary of Evidence-based Guideline for CLINICIANS: ANTIEPILEPTIC DRUG SELECTION FOR PEOPLE WITH HIV/AIDS.
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):287-8. PubMed ID: 26844747
[No Abstract] [Full Text] [Related]
10. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
11. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
12. Protein binding in antiretroviral therapies.
Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
[TBL] [Abstract][Full Text] [Related]
13. [Clinical guidelines for epilepsy].
Tsuji S
Nihon Rinsho; 2014 May; 72(5):803-8. PubMed ID: 24912279
[TBL] [Abstract][Full Text] [Related]
14. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and interactions of antiepileptic drugs.
Graves NM
Am J Hosp Pharm; 1993 Dec; 50(12 Suppl 5):S23-9; quiz S30-2. PubMed ID: 8122698
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
[TBL] [Abstract][Full Text] [Related]
17. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
[TBL] [Abstract][Full Text] [Related]
18. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
19. Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.
Baroncelli S; Villani P; Weimer LE; Ladisa N; Francisci D; Tommasi C; Vullo V; Preziosi R; Cicalini S; Cusato M; Galluzzo C; Floridia M; Regazzi M;
Ann Pharmacother; 2010 May; 44(5):838-43. PubMed ID: 20371753
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
